Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Abbott Laboratories : Recalls Pacemakers Citing Potential Electrical Shock Risk

05/13/2021 | 03:27pm EDT


ę MT Newswires 2021
All news about ABBOTT LABORATORIES
06/23ABBOTT LABORATORIESá : Earns first of its kind recommendation for high school st..
AQ
06/21U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel d..
RE
06/11INSIDER TRENDS : Insider at Abbott Laboratories Tax Sale Continues 90-Day Sellin..
MT
06/11ABBOTT LABORATORIESá : Maintains Quarterly Dividend of $0.45 Per Share, Payable ..
MT
06/11ABBOTTá : Declares 390th Consecutive Quarterly Dividend
PR
06/07INSIDER TRENDS : Abbott Laboratories Insider Sale for Taxes Adds to 90-Day Selli..
MT
06/07INSIDER TRENDS : Insider at Abbott Laboratories Makes Tax Sale Extends 90-Day Se..
MT
06/07ABBOTT LABORATORIESá : and Walgreens Launch Pilot Program to Increase Access to ..
PU
06/04S&P 500 Posts 0.6% Weekly Increase as May Jobs Climb But Miss Expectations; E..
MT
06/04ABBOTT LABORATORIESá : Confirms capacity to support expanded use of heartmate 3 ..
AQ
More news
Financials (USD)
Sales 2021 39 425 M - -
Net income 2021 5 861 M - -
Net Debt 2021 9 307 M - -
P/E ratio 2021 34,1x
Yield 2021 1,52%
Capitalization 198 B 198 B -
EV / Sales 2021 5,27x
EV / Sales 2022 5,20x
Nbr of Employees 109 000
Free-Float 89,0%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 111,70 $
Average target price 124,86 $
Spread / Average Target 11,8%
EPS Revisions
Managers and Directors
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive Vice President
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES2.02%196 943
MEDTRONIC PLC7.13%168 834
BECTON, DICKINSON AND COMPANY-4.00%69 860
HOYA CORPORATION5.01%49 528
ALIGN TECHNOLOGY, INC.13.37%47 943
DEXCOM, INC.16.77%41 750